bibliographic resource 334711 [br/334711]
https://w3id.org/oc/corpus/br/334711

is a
title
  • Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma
publication date
  • 2014-01-01
contributor
format
identifier
part of